You are here

AMBION DIAGNOSTICS, INC.

Company Information
Address
Asuragen, Inc. 2150 WOODWARD ST
AUSTIN, TX -
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. CO-AMPLIFIED RNAS FOR COMPARITIVE MICROARRAY ANALYSIS

    Amount: $120,930.00

    Ambion, Inc. proposes to develop methods and reagents that will make it possible to compare the expression profiles of small RNA samples (

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  2. SIRNA DESIGN, PRODUCTION AND DELIVERY

    Amount: $221,381.00

    DESCRIPTION (provided by applicant): RNA interference is a new and powerful research tool that can be used to down regulate or knock out a specific gene or genes in a variety of cell types and organis ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  3. MULTI-SAMPLE COMPARATIVE RT-PCR

    Amount: $119,783.00

    Ambion, Inc. proposes to adapt its Comparative RT-PCR procedure to accommodate the comparative analysis of single transcripts across one hundred RNA samples. The proposed procedure involves reverse t ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  4. ADVANCING RNA AMPLIFICATION TECHNOLOGIES FOR MICROARRAYS

    Amount: $0.00

    DESCRIPTION (provided by applicant): Probably the most versatile assay for genomic scale research is the high-density microarray. Microarray analysis has the potential for uncovering the complex behav ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  5. ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA

    Amount: $162,362.00

    DESCRIPTION (provided by applicant): Intact RNA is an obligate starting material for expression profiling technologies that can link specific molecular events with disease phenotypes. RNA isolations f ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  6. INNOVATIVE TECHNOLOGY FOR IN VITRO EVOLUTION OF PROTEINS

    Amount: $107,000.00

    DESCRIPTION (provided by applicant): The overall objective of this proposal is to develop a powerful in vitro protein engineering platform that will allow selection or screening of very large numbers ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  7. ADVANCING RNA AMPLIFICATION TECHNOLOGIES FOR MICROARRAYS

    Amount: $1,602,863.00

    DESCRIPTION (provided by applicant): Probably the most versatile assay for genomic scale research is the high-density microarray. Microarray analysis has the potential for uncovering the complex behav ...

    SBIRPhase II2002Department of Health and Human Services National Institutes of Health
  8. SINGLE-STEP DETECTION OF RNA IN CELLS

    Amount: $0.00

    DESCRIPTION (provided by applicant): The overall goal is to develop a "Cells-to-Signal" assay in which a single reagent is added to cells and then used directly for the detection of a specific RNA seq ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  9. SINGLE-STEP DETECTION OF RNA IN CELLS

    Amount: $773,914.00

    DESCRIPTION (provided by applicant): The overall goal is to develop a "Cells-to-Signal" assay in which a single reagent is added to cells and then used directly for the detection of a specific RNA seq ...

    SBIRPhase II2002Department of Health and Human Services National Institutes of Health
  10. IMPROVED METHODS FOR ISOLATING RNA FROM LIMITED SAMPLES

    Amount: $220,853.00

    DESCRIPTION: A need currently exists for methods to quantitatively purify RNA from small-scale samples (1-10,000 cells and tissue amounts ranging from 0.05 - 5 mg). Recent technical advanc ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government